Canadian Rheumatology Association Updated Position Statement on Biosimilars
The Canadian Rheumatology Association has released an updated position statement [...]
Important Safety Information regarding PrBENLYSTA (belimumab)
Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, [...]
Drug Shortage Notification – Methotrexate Injection (Sandoz), 25 mg/ml, 2 ml vial
Drug Name: Methotrexate Injection (Sandoz), 25 mg/ml, 2 ml vial [...]
Canadian Rheumatology Association Position Statement on Medical Cannabis Use in Rheumatic Disease
With the legalization of cannabis on October 17, 2018, Canadians [...]
Drug Shortage Notification
The Canadian Rheumatology Association would like to advise [...]